Cargando…

Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis

The epidemiology and burden of Herpes Zoster (HZ) are largely unknown, and there are no recent reviews summarizing the available evidence from the Latin America and Caribbean (LAC) region. We conducted a systematic review and meta-analysis to characterize the epidemiology and burden of HZ in LAC. Bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardach, Ariel Esteban, Palermo, Carolina, Alconada, Tomás, Sandoval, Macarena, Balan, Darío Javier, Nieto Guevara, Javier, Gómez, Jorge, Ciapponi, Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360515/
https://www.ncbi.nlm.nih.gov/pubmed/34383851
http://dx.doi.org/10.1371/journal.pone.0255877
_version_ 1783737758102061056
author Bardach, Ariel Esteban
Palermo, Carolina
Alconada, Tomás
Sandoval, Macarena
Balan, Darío Javier
Nieto Guevara, Javier
Gómez, Jorge
Ciapponi, Agustin
author_facet Bardach, Ariel Esteban
Palermo, Carolina
Alconada, Tomás
Sandoval, Macarena
Balan, Darío Javier
Nieto Guevara, Javier
Gómez, Jorge
Ciapponi, Agustin
author_sort Bardach, Ariel Esteban
collection PubMed
description The epidemiology and burden of Herpes Zoster (HZ) are largely unknown, and there are no recent reviews summarizing the available evidence from the Latin America and Caribbean (LAC) region. We conducted a systematic review and meta-analysis to characterize the epidemiology and burden of HZ in LAC. Bibliographic databases and grey literature sources were consulted to find studies published (January 2000 –February 2020) with epidemiological endpoints: cumulative incidence and incidence density (HZ cases per 100,000 person-years), prevalence, case-fatality rates, HZ mortality, hospitalization rates, and rates of each HZ complication. Twenty-six studies were included with most studies coming from Brazil. No studies reported the incidence of HZ in the general population. In population at higher risk, the cumulative incidence ranged from 318–3,423 cases of HZ per 100,000 persons per year of follow-up. The incidence density was 6.4–36.5 cases per 1,000 person-years. Age was identified as a major risk factor towards HZ incidence which increase significantly in people >50 years of age. Hospitalization rates ranged from 3%–35.7%. The in-hospital HZ mortality rate ranged from 0%–36%. Overall, HZ mortality rates were found to be higher in females across all age groups and countries. The incidence of HZ complications (such as post-herpetic neuralgia, ophthalmic herpes zoster, and Ramsay Hunt syndrome) was higher in the immunosuppressed compared to the immunocompetent population. Acyclovir was the most frequently used therapy. Epidemiological data from Ministry of Health databases (Argentina, Brazil, Colombia, Chile y Mexico) and Institute for Health Metrics and Evaluation’s Global Burden of Disease project reported stable rates of hospitalizations and deaths over the last 10 years. High-risk groups for HZ impose a considerable burden in LAC. They could benefit from directed healthcare initiatives, including adult immunization, to prevent HZ occurrence and its complications.
format Online
Article
Text
id pubmed-8360515
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83605152021-08-13 Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis Bardach, Ariel Esteban Palermo, Carolina Alconada, Tomás Sandoval, Macarena Balan, Darío Javier Nieto Guevara, Javier Gómez, Jorge Ciapponi, Agustin PLoS One Research Article The epidemiology and burden of Herpes Zoster (HZ) are largely unknown, and there are no recent reviews summarizing the available evidence from the Latin America and Caribbean (LAC) region. We conducted a systematic review and meta-analysis to characterize the epidemiology and burden of HZ in LAC. Bibliographic databases and grey literature sources were consulted to find studies published (January 2000 –February 2020) with epidemiological endpoints: cumulative incidence and incidence density (HZ cases per 100,000 person-years), prevalence, case-fatality rates, HZ mortality, hospitalization rates, and rates of each HZ complication. Twenty-six studies were included with most studies coming from Brazil. No studies reported the incidence of HZ in the general population. In population at higher risk, the cumulative incidence ranged from 318–3,423 cases of HZ per 100,000 persons per year of follow-up. The incidence density was 6.4–36.5 cases per 1,000 person-years. Age was identified as a major risk factor towards HZ incidence which increase significantly in people >50 years of age. Hospitalization rates ranged from 3%–35.7%. The in-hospital HZ mortality rate ranged from 0%–36%. Overall, HZ mortality rates were found to be higher in females across all age groups and countries. The incidence of HZ complications (such as post-herpetic neuralgia, ophthalmic herpes zoster, and Ramsay Hunt syndrome) was higher in the immunosuppressed compared to the immunocompetent population. Acyclovir was the most frequently used therapy. Epidemiological data from Ministry of Health databases (Argentina, Brazil, Colombia, Chile y Mexico) and Institute for Health Metrics and Evaluation’s Global Burden of Disease project reported stable rates of hospitalizations and deaths over the last 10 years. High-risk groups for HZ impose a considerable burden in LAC. They could benefit from directed healthcare initiatives, including adult immunization, to prevent HZ occurrence and its complications. Public Library of Science 2021-08-12 /pmc/articles/PMC8360515/ /pubmed/34383851 http://dx.doi.org/10.1371/journal.pone.0255877 Text en © 2021 Bardach et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bardach, Ariel Esteban
Palermo, Carolina
Alconada, Tomás
Sandoval, Macarena
Balan, Darío Javier
Nieto Guevara, Javier
Gómez, Jorge
Ciapponi, Agustin
Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis
title Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis
title_full Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis
title_fullStr Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis
title_full_unstemmed Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis
title_short Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis
title_sort herpes zoster epidemiology in latin america: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360515/
https://www.ncbi.nlm.nih.gov/pubmed/34383851
http://dx.doi.org/10.1371/journal.pone.0255877
work_keys_str_mv AT bardacharielesteban herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis
AT palermocarolina herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis
AT alconadatomas herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis
AT sandovalmacarena herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis
AT balandariojavier herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis
AT nietoguevarajavier herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis
AT gomezjorge herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis
AT ciapponiagustin herpeszosterepidemiologyinlatinamericaasystematicreviewandmetaanalysis